When establishing the association of SELENOM-KD with the activation of three known UPR pathways (PERK, IRE1α, and ATF6) in the studied cancer cell line, we showed no effect of SELENOM-KD on the expression patterns of three key markers of these signaling pathways. This evidence concerns the gene ATF6 and cancer.